Chinese Mindray Sees Increased International Growth Through U.S. Datascope Acquisition
This article was originally published in PharmAsia News
SHANGHAI - Shenzhen-based Mindray Medical International saw strong international growth through its acquisition of American Datascope's patient monitoring business in May, the company said in a second quarter earnings call Sept. 4
You may also be interested in...
Mindray stock recovers from freefall after allegations that China’s leading medical device company overstated its earnings and engaged in fraudulent accounting practices.
China’s largest medical device company is buying its way to a highly exclusive club of global high-end ultrasound manufacturers. While management expects synergy by marrying American technology with Chinese manufacturing, some see a fragmented strategy trying to offer all things for all people.
BEIJING - With a spike in orders for patient monitors following China's 7.9 magnitude earthquake, Mindray Medical International has ramped up production to supply hospitals throughout the devastated region